##plugins.themes.academic_pro.article.main##

Abstract

Anemia of inflammation (AI), also known as anemia of chronic disease (ACD), is regarded as the most frequent anemia in hospitalized and chronically ill patients. It is prevalent in patients with diseases that cause prolonged immune activation, including infection, autoimmune diseases, and cancer. Given its frequency, it is second only to iron deficiency anemia. Rheumatoid arthritis is one of the most common types of chronic inflammatory arthritis. It is characterized by inflammation (pain, heat, swelling, redness) of the joints, especially of the hands and feet.

Keywords

Rheumatoid Arthritis Anemia Triglycerides GFR

##plugins.themes.academic_pro.article.details##

How to Cite
Dr. Khamis Y. C. Al-Qubaeissy, Dr. Ahmed Sh Muhialdin, & Dr. Zainab N. Muhsin. (2023). Relation between iron deficiency anemia and Rheumatoid Arthritis. Texas Journal of Medical Science, 19, 13–20. https://doi.org/10.62480/tjms.2023.vol19.pp13-20

References

  1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH: National Arthritis Data Workgroup. Part I. Arthritis Rheum. 2008, 58 (1): 15-25. 10.1002/art.23177. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States.
  2. Brooks PM: Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002, 14 (5): 573-577. 10.1097/00002281-200209000-00017.
  3. Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC: The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford). 2005, 44 (12): 1531-1537. 10.1093/rheumatology/kei049.
  4. World Health Organization and the Bone and Joint Decade 2000-2010: The Burden of Musculoskeletal Conditions at the Start of the New Millennium. Report of a WHO Scientific Group. 2003, WHO Technical Report Series No.919. Geneva, Switzerland, Accessed 2 Feb 2009, [http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf]
  5. Kvien TK: Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004, 22 (2 Suppl): 1-12.
  6. Cooper NJ: Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2000, 39 (1): 28-33. 10.1093/rheumatology/39.1.28.
  7. Guillemin F, Durieux S, Daures JP, Lafuma A, Saraux A, Sibilia J, Bourgeois P, Sany J: Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists. J Rheumatol. 2004, 31 (7): 1297-1304.
  8. World Health Organization: Nutritional Anaemias. Report of a WHO Scientific Group. 1968, WHO Technical Report Series No.405, Geneva Switzerland, Accessed 10 Dec 2008,
  9. Spence RK: Medical and economic impact of anaemia in hospitalized patients. Am J Health Syst Pharm. 2007, 64 (16 Suppl 11): S3-10. 10.2146/ajhp070244.
  10. Sharma JB: Nutritional anaemia during pregnancy in non-industrialized countries. Progress in Obstetrics and Gynaecology. Edited by: Studd J. 2003, Edinburgh Churchill Livingstone, 103-122.
  11. Murphy EA, Bell AL, Wojtulewski J, Brzeski M, Madhok R, Capell HA: Study of erythropoietin in the treatment of anaemia in patients with rheumatoid arthritis. BMJ. 1994, 309 (6965): 1337-1338.
  12. Penninx BW, Pahor M, Woodman RC, Guralnik JM: Anemia in old age is associated with increased mortality and hospitalization. J Gerontol a Biol Sci Med Sci. 2006, 61 (5): 474-479.
  13. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M: Anemia and decline in physical performance among older persons. Am J Med. 2003, 115 (2): 104-110. 10.1016/S0002-9343 (03)00263-8.
  14. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, Guralnik JM, Ferrucci L: Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004, 52 (5): 719-724. 10.1111/j.1532-5415.2004.52208. x.
  15. Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, Fried LP: Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol a Biol Sci Med Sci. 2005, 60 (6): 729-735.
  16. Ershler WB, Chen K, Reyes EB, DuBois R: Economic burden of patients with anemia in selected diseases. Value Health. 2005, 8 (6): 629-638.
  17. Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW: Economic burden of anemia in an insured population. J Manag Care Pharm. 2005, 11 (7): 565-574.
  18. College des Economistes de la Sante (CES): Guide Methodologique pour l'evaluation economique des Strategies de Sante. Accessed 18 Aug 2010, [http://www.rees-france.com/article.php3?id_article=126]
  19. World Health Organization: International Classification of Diseases (ICD). Accessed 18 Aug 2010, [http://www.who.int/classifications/icd/en/]
  20. Assaf AR, Lapane KL, McKenney JL, Carleton RA: Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med. 1993, 329 (13): 931-935. 10.1056/NEJM199309233291307.
  21. Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ: Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002, 347 (26): 2104-2110. 10.1056/NEJMoa021907.
  22. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C: Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. 2003, 124 (2): 288-292. 10.1053/gast.2003.50054.
  23. Hawkey CJ: NSAIDs, coxibs, and the intestine. J Cardiovasc Pharmacol. 2006, 47 (Suppl 1): S72-S75. 10.1097/00005344-200605001-00013.
  24. Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med. 2005, 352 (10): 1011-1023. 10.1056/NEJMra041809.